Transcat (TRNS) closed at $106.33 on November 12, 2026, up 1.2% from the previous close, on volume of 191,524 shares (30-day average 163,454).
Data as of November 12, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 9, 2026 | Call with Delta Hedge | 17-Jun-27 145 C +9,600 Stock | 400 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
Business Wire (Tue, 3-Nov 4:01 PM ET)
Transcat to Attend Upcoming Investor Conferences in November
Business Wire (Mon, 2-Nov 8:31 AM ET)
Transcat Sets Nov. 3 Conference Call as Shares Trade at $84.99 Mid-Morning
Market Chameleon (Wed, 21-Oct 6:46 AM ET)
Business Wire (Tue, 20-Oct 8:31 AM ET)
Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical
Business Wire (Mon, 31-Aug 9:00 AM ET)
Business Wire (Thu, 27-Aug 8:31 AM ET)
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.
Transcat trades on the NASDAQ stock market under the symbol TRNS.
As of November 12, 2026, TRNS stock price climbed to $106.33 with 191,524 million shares trading.
TRNS has a beta of 0.91, meaning it tends to be less sensitive to market movements. TRNS has a correlation of 0.05 to the broad based SPY ETF.
TRNS has a market cap of $995.23 million. This is considered a Small Cap stock.
Last quarter Transcat reported $97 million in Revenue and $.64 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.20.
In the last 3 years, TRNS traded as high as $147.12 and as low as $50.23.
The top ETF exchange traded funds that TRNS belongs to (by Net Assets): IWM, VTI, TSME, VXF, DFAT.
TRNS has outperformed the market in the last year with a price return of +87.9% while the SPY ETF gained +12.0%. TRNS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +11.5% and +19.7%, respectively, while the SPY returned -1.5% and -2.0%, respectively.
TRNS support price is $101.65 and resistance is $108.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TRNS shares will trade within this expected range on the day.
